Initial reporter phone#: (b)(6).Investigation: dhr review for batch #7120875 (p/n 309658): manufacturing dates: 5/12/2017 ¿ 5/13/2017.All visual inspections were performed as per requirement with no quality notifications related to the complaint defect.Batch 7120875 was inspected and accepted based on meeting our inspection control plan and subsequently approved for shipment.Sample evaluation: various samples in their original sealed packaging received and evaluated: - two 10ml plastipak syringes from lot #1706012p (p/n 305959) ¿ not canaan product.- three 5ml plastipak syringes from lot #7086514 (p/n 309649) ¿ canaan¿s product.- three 3ml plastipak syringes from lot #7120875 (p/n 309658) ¿ canaan¿s product.- three bd eclipse needles with smartslip from lot #1705003 (p/n 305760) ¿ not canaan product.Visual inspection did not reveal any defects in any of the samples received.A bd eclipse needle was then attached to different syringe samples, including 10ml, 5ml, and 3ml.It was observed that when being attached to the 3ml samples, the hub tightened sooner than when attaching to 5ml or 10ml samples.The connection was still secure.There was no difficulty connecting the needle up to the point it felt tight for any of the samples.The investigation discovered that the luer collar was the same in all of the samples and has no taper.The difference between the samples was the syringe tip, which has a taper.An iso 594/1 ring gage tool was used to verify the taper on all of the samples.The 3ml samples were at the lower end of the range than the 5ml and 10ml samples, which means the 3ml samples have a slightly higher degree of taper ¿ the tip widens faster.This would explain the observed difference when connecting to needle hubs and other luer lock devices.The result would be the tips on the 3ml syringes completing the connection sooner than 5ml or 10ml used in this investigation.However, all samples were within the specified iso range and all of the samples are acceptable for use.It is not recommended to force any devices past the point of a snug, secure connection.Based on the sample evaluation: unconfirmed: bd canaan was not able to duplicate or confirm the customer's indicated failure.Based on the fact that no defect was found, capa is not required at this time.Udi#: (b)(4).
|